60 Degrees Pharmaceuticals Balance Sheet (2022-2025) | SXTP

Balance Sheet Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Accumulated Depreciation 0.15M0.15M0.14M0.14M0.15M0.15M0.16M0.18M
Assets
Current Assets
Cash & Equivalents 0.75M0.44M0.26M0.03M0.02M2.22M2.14M2.89M1.58M3.30M3.39M3.45M1.97M4.12M
Receivables - Net 0.05M0.13M0.14M0.23M0.32M0.30M0.32M0.49M0.49M0.30M0.67M
Receivables 0.05M0.13M0.14M0.23M0.32M0.30M0.32M0.49M0.49M0.30M0.67M
Raw Materials 0.35M0.35M
Work In Process 0.28M0.28M0.31M0.37M0.28M0.28M0.25M
Finished Goods 0.19M0.16M0.12M0.08M0.16M0.14M0.21M
Inventory 0.68M0.74M0.68M0.47M0.44M0.43M0.45M0.44M0.77M0.80M0.77M
Prepaid Assets 0.20M4.85M5.94M4.40M4.26M1.46M1.10M1.07M0.94M0.78M0.99M
Current Assets 1.10M5.67M8.89M7.24M7.91M3.76M6.89M5.39M5.65M3.84M6.31M
Non-Current Assets
Property, Plant & Equipment (Net) 0.02M0.01M0.00M0.06M0.06M0.16M0.16M0.15M0.16M0.19M0.23M
Intangibles 0.16M0.23M0.25M0.26M0.22M0.31M0.33M0.23M0.24M0.24M0.26M
Goodwill & Intangibles 0.16M0.23M0.25M0.26M0.22M0.31M0.33M0.23M0.24M0.24M0.26M
Long-Term Deferred Tax 3.34M1.00M3.74M
Other Non-Current Assets 0.18M1.68M0.25M0.48M0.42M0.40M0.37M0.22M0.17M0.14M0.15M
Non-Current Assets 0.20M1.68M0.26M0.54M0.47M0.56M0.53M0.37M0.33M0.34M0.38M
Assets 1.30M7.36M9.15M7.78M8.38M4.33M7.42M5.76M5.98M4.18M6.69M
Liabilities
Current Liabilities
Accounts Payables 0.76M1.06M0.27M0.51M0.53M0.64M0.68M1.01M1.16M0.91M1.39M
Notes Payables 16.86M25.99M2.17M
Payables 17.61M27.04M2.45M0.51M0.53M0.64M0.68M1.01M1.16M0.91M1.39M
Accumulated Expenses 0.33M0.07M0.29M0.07M
Short term Debt 1.49M23.54M2.17M2.31M0.57M0.57M0.62M0.64M0.64M0.78M0.80M
Current Leases 0.01M0.04M0.03M0.01M
Total Current Liabilities 23.92M28.86M2.48M2.84M1.10M1.22M1.31M1.66M1.80M1.69M2.20M
Non-Current Liabilities
Non-Current Debt 1.11M1.22M
Non-Current Deffered Revenue 0.26M
Minority Interest -0.57M-0.58M-0.04M-0.07M-0.07M-0.08M-0.08M-0.08M-0.08M-0.08M-0.08M
Operating Leases 0.04M0.03M
Non-Current Deferred Tax Liability 0.70M
Other Non-Current Liabilities 1.49M1.50M0.07M0.57M
Total Non-Current Liabilities 1.53M19.87M1.37M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.14M
Total Liabilities 21.04M22.50M25.45M21.37M30.24M2.63M2.99M1.25M1.37M1.46M1.80M1.95M1.84M2.34M
Shareholder's Equity
Total Debt 2.60M24.76M2.17M2.31M0.57M0.57M0.62M0.64M0.64M0.78M0.80M
Common Equity -21.04M-22.50M-24.15M-21.37M-24.71M6.52M4.80M7.13M2.96M5.96M4.04M4.03M2.35M4.43M
Shareholder's Equity -21.04M-22.50M-24.15M-21.37M-24.71M6.52M4.80M7.13M2.96M5.96M4.04M4.03M2.35M4.43M
Liabilities and Shareholders Equity 1.30M7.36M9.15M7.78M8.38M4.33M7.42M5.76M5.98M4.18M6.69M
Retained Earnings -28.82M-34.75M-30.57M-32.58M-32.15M-36.32M-38.48M-40.53M-42.40M-44.14M-46.45M
Preferred Shares 9.86M9.86M9.86M9.86M9.57M9.57M9.57M9.57M9.57M
Treasury Shares 0.41M0.26M0.05M0.93M0.18M9.80M1.77M2.13M2.13M7.59M
Shares Outstanding 2.39M2.39M0.04M0.20M0.20M0.48M0.10M0.20M0.20M0.37M0.57M1.47M1.47M4.10M